Silmitasertib Unknown Status Phase 1 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01199718Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma